Profound Medical Corp. (TSX:PRN)

Profound Medical Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	341	391	324	267	302	296
Market Cap Growth	70.55%	20.53%	21.57%	-11.75%	2.07%	-42.38%
Enterprise Value	266	363	296	232	240	207
Last Close Price	9.39	10.77	10.80	11.10	14.48	14.26
PS Ratio	15.46	17.71	21.10	28.06	33.43	34.05
PB Ratio	3.75	4.29	3.73	6.47	4.30	2.90
P/TBV Ratio	3.75	4.30	3.75	6.57	4.35	3.06
EV/Sales Ratio	12.04	16.44	19.27	24.43	26.58	23.77
Debt / Equity Ratio	0.07	0.07	0.09	0.25	0.16	0.02
Net Debt / Equity Ratio	-0.83	-0.83	-0.82	-0.59	-0.74	-0.82
Net Debt / EBITDA Ratio	1.35	1.35	1.55	0.66	1.33	2.22
Net Debt / FCF Ratio	1.43	1.43	2.12	0.81	1.48	2.94
Asset Turnover	0.22	0.22	0.19	0.13	0.09	0.07
Inventory Turnover	0.67	0.67	0.57	0.39	0.48	0.62
Quick Ratio	11.02	11.02	9.44	5.26	12.63	16.50
Current Ratio	12.53	12.53	10.52	6.58	14.82	18.56
Return on Equity (ROE)	-67.12%	-67.12%	-60.70%	-68.06%	-43.23%	-34.50%
Return on Assets (ROA)	-34.91%	-34.91%	-36.19%	-33.05%	-24.47%	-19.79%
Return on Capital Employed (ROCE)	-57.80%	-57.80%	-51.90%	-76.20%	-49.10%	-36.70%
Earnings Yield	-17.11%	-14.93%	-12.34%	-14.02%	-12.84%	-13.12%
FCF Yield	-15.42%	-13.46%	-10.41%	-11.19%	-11.55%	-9.57%
Buyback Yield / Dilution	-22.08%	-22.08%	-16.91%	-1.69%	-1.79%	-18.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.